• Working in the present,
    thinking the future

  • Health, our greatest asset value

  • Pharmacovigilance

  • Patient Centricity

We provide drugs with a high added value for health care and treatments for high complexity diseases, for both overall patients and the medical and scientific community

Our products

are mainly addressed to be used in hematologic, oncologic, urologic and neurologic pathologies as well as rare diseases

Products

Hematology
Oncology
Neurology
Urology
Rare diseases

News

New release LIPECELTE® trabectedin

23/12/2024

Introducing LIPECELTE® Trabectedin: A New Addition to Our Oncology Line At Bioprofarma Bagó, we reaffirm our dedication to patient care with the launch of LIPECELTE® trabectedin, approved by ANMAT for the treatment of: – Advanced soft tissue sarcoma (STS) in adult patients who have failed anthracycline and ifosfamide treatment or are not candidates for these […]

Read note

(Español) Jornada de Uro Oncología FUCDIM

24/10/2024

Sorry, this entry is only available in European Spanish.

Read note

(Español) Jornada URO ONCOSESSIONS V

18/10/2024

Sorry, this entry is only available in European Spanish.

Read note

Bioprofarma Bagó worldwide